Docosahexaenoic Acid Market Trends

  • Report ID: 3946
  • Published Date: Jun 07, 2024
  • Report Format: PDF, PPT

Docosahexaenoic Acid Market Trends

Growth Drivers

  • Increase in Unhealthy Eating Habits - Unhealthy eating practices encompass undereating or overeating, not getting enough of the essential nutrients we need every day, or taking an excessive amount of low-fiber, high-fat, and sugar-containing foods and beverages. Such kind of food items deliver more harm to our overall health and even increases the death toll.
    The surge in unhealthy eating habits has been increasing the tendency to consume DHA as dietary supplements to get the required amount of essential nutrients for overall health, which is projected to fuel market growth. According to a global report, in 2021, nearly 49% of people ate either too little or too much.
  • Rising Disposable Income – Disposable income naturally leads to a growth in consumption. Based on Bureau of Economic Analysis data, by March 2022, personal income and disposable personal income (DPI) in the United States climbed by 107.2 billion and USD 89.7 billion respectively.

Challenges

  • Associated Side Effects of Docosahexaenoic Acid (DHA) - Though DHA is safe and very beneficial for the overall health of a person. But still, some rising side effects of DHA comprising headache, bad breath, bad taste, bloating, and so on are anticipated to limit people from consuming products containing docosahexaenoic acid. Moreover, taking DHA in the form of fish oil can also have a variety of side effects, such as heartburn, and nausea. Hence, this factor is anticipated to dampen the market growth over the projected time frame.
  • Unstable Supply of Raw Materials
  • High Cost of Concentrated DHA

Docosahexaenoic Acid Market: Key Insights

Base Year

2023

Forecast Year

2024-2036

CAGR

10%

Base Year Market Size (2023)

USD 4.1 Billion

Forecast Year Market Size (2036)

USD 13.62 Billion

Regional Scope

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Parul Atri


  • Report ID: 3946
  • Published Date: Jun 07, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of docosahexaenoic acid is estimated at USD 4.42 Billion.

The docosahexaenoic acid market size was over USD 4.1 Billion in 2023 and is poised to cross USD 13.62 Billion by the end of 2036, witnessing more than 10% CAGR during the forecast period i.e., between 2024-2036. Escalating cases of depression and surging risk of preterm births across the globe are the major factors driving the growth of the market.

Asia Pacific industry is predicted to account for the largest share of about 42% by 2036, impelled by growing healthcare expenditure in the region.

Koninklijke DSM N.V., BASF SE, Croda International Plc, Cellana, Inc., Far East Microalgae Industries, Co., Ltd.(FEMICO), Pelagia AS, Corbion NV, JC Biotech Private Limited, Source Omega LLC, Shandong Yuexiang Biotechnology Co., Ltd.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample